🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Now Available: The AACE Patient Guide to Rare Endocrine Diseases: Cushing's Syndrome offers easy to understand evidence-based information on symptoms, treatment options, and lifestyle changes. Share this new resource with your patients today: aace.com/cushings-syndr…

From #AACE2025: Compared with placebo, #crinecerfont was associated with lower #glucocorticoid dosing needs and improved #hormone control in pediatric #CongenitalAdrenalHyperplasia. AACE endocrinologyadvisor.com/reports/crinec…

From #AACE2025: #CAM2029, a subcutaneous octreotide depot, was associated with improved disease severity, quality of life, and treatment satisfaction among patients with #acromegaly. AACE endocrinologyadvisor.com/reports/cam202…

📣"THRIVE-2 is the first randomized controlled trial of IGF-I inhibitor inhibition in chronic #thyroid eye disease to show significant improvement not only in proptosis, but in double vision.” #WeAreAACE AACE #AACE2025 Ocular Surgery News Rutgers New Jersey Medical School healio.com/news/endocrino…

🎧 New AACE podcast! In this episode, Dr. Jaime Almandoz, MD MBA FTOS, Associate Professor of Medicine at UT Southwestern, is joined by Dr Robert Kushner, Professor of Medicine at Northwestern University and a leading authority in obesity medicine, to discuss the recent Lancet Diabetes &

🎧 New AACE podcast! In this episode, Dr. Jaime Almandoz, MD MBA FTOS, Associate Professor of Medicine at UT Southwestern, is joined by Dr Robert Kushner, Professor of Medicine at Northwestern University and a leading authority in obesity medicine, to discuss the recent Lancet Diabetes &

More than 4 in 10 U.S. adults have obesity. Some of them are your patients. Support their path forward with the new AACE Journey for Patients With Obesity. Available now: aace.com/patient-journe… #endocrinology

Delighted to be able to contribute to those guidelines AACE WashU Medicine Endocrinology WashU Medicine

📣"There were sustained benefits through 2 years, with independence from conventional therapy, nobody on active [vitamin] D, and if they were on calcium, it was 600 mg or less." #AACE2025 AACE AscendisPharma healio.com/news/endocrino…

This free program aims to equip primary care professionals with the skills to manage type 2 diabetes more effectively, particularly those who may be hesitant to prescribe glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Register: pro.aace.com/education-and-… #endocrinology

📢 Just Launched! AACE Endocrinology and Diabetes (AED) Now available! AACE’s open access journal. AED accepts original research, reviews, case reports, visual and video vignettes. Read the editorial by Editor-in-Chief, Dr. Vin Tangpricha: endocrinologydiabetes.org/article/S3050-…

🩺 A small group of adults with low-risk papillary #thyroid carcinoma who opted for radiofrequency ablation had declines in tumor volume at 1 year, according to data presented by Sean P. Nikravan, MD, FACE at #AACE2025. AACE HemOnc Today healio.com/news/endocrino…

Join the new AACE Topical Interest Groups on Facebook! 🔎 Artificial Intelligence (AI) & Clinical Endocrinology Community 🔎 Environmental Endocrinology Community

📢 Just Launched! AACE Endocrinology and Diabetes (AED) Now available! AACE’s open access journal. AED accepts original research, reviews, case reports, visual and video vignettes. Read the editorial by Editor-in-Chief, Dr. Vin Tangpricha: endocrinologydiabetes.org/article/S3050-…

Gain practical experience through interactive case studies. The Obesity and Weight Loss Certificate Program provides healthcare professionals with in-depth knowledge and practical tools to manage and treat obesity and its related health conditions. Learn more and register:

This case includes the use of alpelisib for long-term treatment of tumor-induced hypoglycemia in 2 patients with insulin-producing or proinsulin-producing tumors: endocrinologydiabetes.org/article/S3050-… #endocrinology #diabetes Vin Tangpricha, MD, PhD Elsevier Endocrinology & Diabetes

This finding from the Osteonecrosis of the Jaw Taskforce supports the safe placement of implants without discontinuation of antiresorptive therapy used for osteoporosis management: endocrinepractice.org/article/S1530-… #endocrinology #diabetes Elsevier Endocrinology & Diabetes Vin Tangpricha, MD, PhD

This case report highlights the potential of tirzepatide in treating hypothalamic obesity (HO), a rare and challenging condition: endocrinologydiabetes.org/article/S3050-… #endocrinology #diabetes Vin Tangpricha, MD, PhD Elsevier Endocrinology & Diabetes

Managing thyroid disease can be challenging and confusing. Use the Thyroid Patient Journey to navigate your thyroid condition. Each step of the journey covers a different part of part of your thyroid disease experience. Learn more: aace.com/patient-journe… #endocrinology

AACE CEO Johnnie White reflects on our shared accomplishments from May and offers a look ahead at key engagements planned for this month: pro.aace.com/recent-news-an… Johnnie White, CEO #WeAreAACE